The Aducanumab Controversy: Accelerated FDA Approval Leads to Agency Distrust07/20/2024 majac Heart Disease … cardiovascular disease. Scientists have validated LDL as a marker of heart disease and justified the use of lipid-lowering drugs due to their …Share on FacebookTweetFollow usSave